Shukra Pharmaceuticals Limited (BOM:524632)
India · Delayed Price · Currency is INR 51.96
-0.04 (-0.08%)
At close: Sep 4, 2026
Shukra Pharmaceuticals Market Cap
Shukra Pharmaceuticals has a market cap or net worth of 22.84 billion as of September 4, 2026. Its market cap has increased by 87.58% in one year.
Market Cap
22.84B
Enterprise Value
22.83B
Revenue
748.59M
Ranking
n/a
PE Ratio
64.28
Stock Price
51.96
ChartMarket Cap Chart
Since February 23, 2012, Shukra Pharmaceuticals's market cap has increased from 46.16M to 22.84B, an increase of 49,383.93%. That is a compound annual growth rate of 53.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 22.84B | -11.96% |
| Dec 31, 2025 | 25.94B | 334.48% |
| Dec 31, 2024 | 5.97B | 340.79% |
| Dec 29, 2023 | 1.35B | 554.74% |
| Dec 30, 2022 | 206.90M | 58.55% |
| Dec 30, 2021 | 130.50M | 105.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novartis India | 40.42B |
| Unichem Laboratories | 38.79B |
| Kwality Pharmaceuticals | 34.18B |
| Hikal | 27.40B |
| Fredun Pharmaceuticals | 24.38B |
| Venus Remedies | 22.58B |
| Syncom Formulations (India) | 19.33B |
| TTK Healthcare | 15.55B |